Browsing by Subject "Randomized controlled-trial"
Now showing items 1-2 of 2
-
(Wiley-Blackwell, 2016)BackgroundTofacitinib is an oral Janus kinase inhibitor that is being investigated for psoriasis. Psoriasis impacts on physical and psychological well-being; improvements in health-related quality of life (HRQoL) with ...
-
(Springer, 2018)Although multiple treatments have been advocated for complex regional pain syndrome (CRPS), the levels of supportive evidence are variable and sometimes limited. The purpose of this updated review is to provide a critical ...